Work

Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors

Year: 2008

Type: article

Source: Oncogene

DOI: 10.1038/onc.2008.49

Authors: L S Steelman, P M Navolanic, M L Sokolosky, J R Taylor, B D Lehmann, W H Chappell, S L Abrams, E W T Wong, K M Stadelman, D M Terrian, N R Leslie, A M Martelli, F Stivala, M Libra, R A Franklin, J A McCubrey

Institutions: East Carolina University, University of Dundee, University of Bologna, University of Catania

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Award: Ras/Raf & PI3K/Akt Induced Breast Cancer Drug Resistance

OpenAlex ID: W2076203883

FWCI: 4.547

Cites: 43

Cited by: 172

Related to: 10